The indictment alleges that on Jan. 31, 2022, Mr. Falzarano, 37, took five vials of lorazepam solution he knew was intended to be distributed to patients, removed the medication solution from the vials, replaced it with saline and returned the vials to be used in medical procedures, according to an Oct. 6 news release from the Justice Department. Mr. Falzarano pleaded not guilty to the charges.
Mr. Falzarnao’s nursing license is currently suspended. If convicted, each charge carries a maximum imprisonment of 10 years, according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
